Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Privia Health Gr
(NASDAQ:PRVA)
Intraday
$16.15
-0.75
[-4.44%]
After-Hours
$16.15
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$16.15
-0.75
[-4.44%]
At close: May 20
$16.15
0
[0.00%]
After Hours: 4:35PM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Privia Health Gr Stock (NASDAQ:PRVA)
Privia Health Gr Stock (NASDAQ: PRVA)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, May 20, 2024
Barclays Maintains Equal-Weight on Privia Health Gr, Lowers Price Target to $19
Benzinga Newsdesk
-
8 hours ago
Wednesday, May 15, 2024
What 12 Analyst Ratings Have To Say About Privia Health Gr
Benzinga Insights
-
5 days ago
Truist Securities Maintains Buy on Privia Health Gr, Lowers Price Target to $24
Benzinga Newsdesk
-
5 days ago
Friday, May 10, 2024
Canaccord Genuity Maintains Buy on Privia Health Gr, Lowers Price Target to $26
Benzinga Newsdesk
-
May 10, 2024, 2:46PM
Thursday, May 09, 2024
Privia Health shares are trading lower after the company reported a Q1 revenue miss.
Benzinga Newsdesk
-
May 9, 2024, 12:30PM
Privia Health Reiterates FY24 Guidance; Revenue Of $1.6B-$1.675B, Est $2.844B
Benzinga Newsdesk
-
May 9, 2024, 6:30AM
Privia Health Gr Q1 2024 Adj EPS $0.18 Beats $0.05 Estimate, Sales $415.243M Miss $679.999M Estimate
Benzinga Newsdesk
-
May 9, 2024, 6:11AM
Wednesday, May 01, 2024
Stifel Maintains Buy on Privia Health Gr, Lowers Price Target to $24
Benzinga Newsdesk
-
May 1, 2024, 9:22AM
Monday, April 22, 2024
Where Privia Health Gr Stands With Analysts
Benzinga Insights
-
Apr 22, 2024, 12:00PM
Citigroup Initiates Coverage On Privia Health Gr with Buy Rating, Announces Price Target of $25
Benzinga Newsdesk
-
Apr 22, 2024, 9:01AM
Tuesday, March 19, 2024
Analyst Scoreboard: 8 Ratings For Privia Health Gr
Benzinga Insights
-
Mar 19, 2024, 11:01AM
Canaccord Genuity Maintains Buy on Privia Health Gr, Lowers Price Target to $37
Benzinga Newsdesk
-
Mar 19, 2024, 6:46AM
Wednesday, March 06, 2024
JP Morgan Maintains Overweight Rating for Privia Health Gr: Here's What You Need To Know
Benzinga Insights
-
Mar 6, 2024, 12:00PM
JP Morgan Maintains Overweight on Privia Health Gr, Lowers Price Target to $30
Benzinga Newsdesk
-
Mar 6, 2024, 11:16AM
Barclays Initiates Coverage On Privia Health Gr with Equal-Weight Rating, Announces Price Target of $22
Benzinga Newsdesk
-
Mar 6, 2024, 6:57AM
Friday, March 01, 2024
UBS Maintains Buy on Privia Health Gr, Lowers Price Target to $29
Benzinga Newsdesk
-
Mar 1, 2024, 11:52AM
TD Cowen Maintains Outperform on Privia Health Gr, Lowers Price Target to $26
Benzinga Newsdesk
-
Mar 1, 2024, 8:32AM
Thursday, February 29, 2024
Forecasting The Future: 4 Analyst Projections For Privia Health Gr
Benzinga Insights
-
Feb 29, 2024, 12:01PM
Truist Securities Maintains Buy on Privia Health Gr, Lowers Price Target to $28
Benzinga Newsdesk
-
Feb 29, 2024, 9:23AM
Wednesday, February 28, 2024
Evercore ISI Group Maintains Outperform on Privia Health Gr, Lowers Price Target to $25
Benzinga Newsdesk
-
Feb 28, 2024, 12:23PM
Tuesday, February 27, 2024
Privia Health Group shares are trading higher after the company reported better-than-expected Q4 adjusted EPS results.
Benzinga Newsdesk
-
Feb 27, 2024, 1:32PM
Privia Health Group Expects FY24 Revenue of $1.600B-$1.675B Vs $3.24B Est
Benzinga Newsdesk
-
Feb 27, 2024, 6:17AM
Privia Health Gr Q4 2023 Adj EPS $0.15 Beats $0.04 Estimate, Sales $440.83M Miss $730.89M Estimate
Benzinga Newsdesk
-
Feb 27, 2024, 6:05AM
Earnings Scheduled For February 27, 2024
Benzinga Insights
-
Feb 27, 2024, 5:01AM
Monday, February 26, 2024
Privia Health Gr's Earnings: A Preview
Benzinga Insights
-
Feb 26, 2024, 10:02AM
Thursday, February 22, 2024
B of A Securities Downgrades Privia Health Gr: Here's What You Need To Know
Benzinga Insights
-
Feb 22, 2024, 12:00PM
B of A Securities Downgrades Privia Health Gr to Neutral, Lowers Price Target to $21
Benzinga Newsdesk
-
Feb 22, 2024, 9:32AM
Monday, January 29, 2024
Why Panbela Therapeutics Shares Are Trading Lower By 65%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
-
Jan 29, 2024, 2:09PM
Wednesday, December 06, 2023
JMP Securities Initiates Coverage On Privia Health Gr with Market Outperform Rating, Announces Price Target of $27
Benzinga Newsdesk
-
Dec 6, 2023, 5:56AM
Friday, November 17, 2023
JP Morgan Maintains Overweight on Privia Health Gr, Lowers Price Target to $38
Benzinga Newsdesk
-
Nov 17, 2023, 11:07AM
Friday, November 03, 2023
Privia Health shares are trading higher after the company reported mixed Q3 financial results and issued FY23 guidance.
Benzinga Newsdesk
-
Nov 3, 2023, 12:48PM
Expedia Group, Gartner, Cloudflare, Cardinal Health And Other Big Stocks Moving Higher On Friday
Lisa Levin
-
Nov 3, 2023, 11:30AM
Earnings Scheduled For November 3, 2023
Benzinga Insights
-
Nov 3, 2023, 7:12AM
Privia Health Expects FY23 GAAP Revenue In Mid To High End Of $1.55B-$1.65B Range Vs. Consensus Of $2.79B; Sees Adjusted EBITDA In Mid to High End Of $70M-$74M
Benzinga Newsdesk
-
Nov 3, 2023, 6:39AM
Privia Health Gr Q3 Adj. EPS $0.17 Beats $0.05 Estimate, Sales $417.28M Miss $702.46M Estimate
Benzinga Newsdesk
-
Nov 3, 2023, 6:33AM
Thursday, November 02, 2023
Preview: Privia Health Gr's Earnings
Benzinga Insights
-
Nov 2, 2023, 12:01PM
Friday, September 15, 2023
Why Novonix Shares Are Trading Higher By 27%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin
-
Sep 15, 2023, 12:40PM
Friday, August 25, 2023
Privia Health Reports Results In CMS' Medicare Shared Savings Program For The 2022 Performance Year
Happy Mohamed
-
Aug 25, 2023, 8:34AM
Friday, August 18, 2023
4 Analysts Have This to Say About Privia Health Gr
Benzinga Insights
-
Aug 18, 2023, 2:00PM
UBS Maintains Buy on Privia Health Gr, Lowers Price Target to $32
Benzinga Newsdesk
-
Aug 18, 2023, 9:17AM
Tuesday, August 15, 2023
TD Cowen Maintains Outperform on Privia Health Gr, Lowers Price Target to $35
Benzinga Newsdesk
-
Aug 15, 2023, 8:22AM
Thursday, August 03, 2023
Privia Health Expects FY23 GAAP Revenue At Mid To High End Of Prior $1,55B-$1.65B Outlook
Benzinga Newsdesk
-
Aug 3, 2023, 8:16AM
Earnings Scheduled For August 3, 2023
Benzinga Insights
-
Aug 3, 2023, 6:59AM
Privia Health Gr Q2 Adj EPS $0.17 Beats $0.05 Estimate, Sales $413.35M Beat $392.34M Estimate
Benzinga Newsdesk
-
Aug 3, 2023, 6:31AM
Tuesday, July 11, 2023
Velocity, Privia Health Enter Partnership To Open Embedded Clinical Research Sites Within Practice Network
Benzinga Newsdesk
-
Jul 11, 2023, 7:15AM
Thursday, June 22, 2023
Credit Suisse Reiterates Outperform on Privia Health Gr, Maintains $41 Price Target
Benzinga Newsdesk
-
Jun 22, 2023, 7:47AM
Tuesday, June 13, 2023
Benzinga's Top Ratings Upgrades, Downgrades For June 13, 2023
Benzinga Insights
-
Jun 13, 2023, 11:00AM
Evercore ISI Group Initiates Coverage On Privia Health Gr with Outperform Rating, Announces Price Target of $34
Benzinga Newsdesk
-
Jun 13, 2023, 4:55AM
Thursday, June 08, 2023
Carvana, Designer Brands, REV Group And Other Big Stocks Moving Higher On Thursday
Lisa Levin
-
Jun 8, 2023, 10:55AM
Privia Health Group shares are trading higher after S&P Dow Jones Indices said the company will replace Ruth's Hospitality in S&P Smallcap 600.
Benzinga Newsdesk
-
Jun 8, 2023, 10:37AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch